Biotech companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Gilead Sciences has the lowest figure of the 20 biotech companies in the United States ranked by short interest, at 1.72%, followed by Amgen (2.33%) and Biogen (3.69%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
20
Lowest
Gilead Sciences1.72%
Median
9.77%
Combined market value
$742.5B
Countries
1

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Biotech companies in the United States by short interest
#CompanyShort interest % ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health Care1.72%$209.6B$168.98 0.75% down 35% up United States
2AmgenAMGN · Health Care2.33%$240.1B$443.89 3.07% down 32% up United States
3BiogenBIIB · Health Care3.69%$37.2B$251.41 0.25% up 49% up United States
4Bio-TechneTECH · Health Care4.90%$11.4B$72.75 0.17% up 24% up United States
5Neurocrine BiosciencesNBIX · Health Care5.83%$16.5B$162.86 1.84% down 17% up United States
6Revolution MedicinesRVMD · Health Care6.05%$34.6B$159.82 1.76% down 129% up United States
7Adaptive BiotechnologiesADPT · Health Care7.09%$4.6B$28.46 0.11% down 74% up United States
8ModernaMRNA · Health Care8.20%$79.6B$196.79 4.84% down 780% up United States
9ImmunovantIMVT · Health Care8.96%$6.9B$33.17 0.12% down 46% up United States
10VaxcytePCVX · Health Care9.70%$9.3B$58.52 1.48% down 23% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%$10.3B$121.13 0.32% down 87% up United States
12Krystal BiotechKRYS · Health Care10.3%$9.3B$315.34 5.62% up 54% up United States
13CG OncologyCGON · Health Care10.3%$7.1B$80.00 1.34% up 97% up United States
14ExelixisEXEL · Health Care10.5%$16.7B$68.29 0.31% down 63% up United States
15RepligenRGEN · Health Care11.0%$11B$172.67 6.47% up 12% up United States
16ImmunityBioIBRX · Health Care11.9%$7.1B$6.70 7.03% up 232% up United States
17Halozyme TherapeuticsHALO · Health Care12.0%$10.9B$95.80 0.18% down 39% up United States
18Kodiak SciencesKOD · Health Care12.4%$6.4B$97.81 1.04% up 399% up United States
19Twist BioscienceTWST · Health Care14.4%$7.9B$116.35 3.88% up 346% up United States
20Scholar Rock HoldingSRRK · Health Care19.2%$5.9B$48.00 6.48% up 26% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further.

Questions and answers

Which biotech companies in the United States have the lowest short interest?

Gilead Sciences (1.72%), Amgen (2.33%) and Biogen (3.69%) have the lowest short interest of the 20 biotech companies in the United States ranked here as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by short interest.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by short interest have a combined market value of $742.5B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies in the United States by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.